| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |